- Previous Close
6.50 - Open
7.00 - Bid 6.00 x --
- Ask --
- Day's Range
6.00 - 7.00 - 52 Week Range
6.00 - 11.75 - Volume
123,166 - Avg. Volume
139,230 - Market Cap (intraday)
12.319M - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
www.abingdonhealth.comRecent News: ABDX.L
View MorePerformance Overview: ABDX.L
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABDX.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABDX.L
View MoreValuation Measures
Market Cap
12.32M
Enterprise Value
9.66M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.18
Price/Book (mrq)
1.92
Enterprise Value/Revenue
1.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.94%
Return on Assets (ttm)
-20.26%
Return on Equity (ttm)
-62.83%
Revenue (ttm)
6.82M
Net Income Avi to Common (ttm)
-2.59M
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
3.67M
Total Debt/Equity (mrq)
15.71%
Levered Free Cash Flow (ttm)
-1.48M